Cube Pharmaceuticals (003020.SZ): Application for marketing of dextromethylene hydrochloride as an API approved

Zhitong Finance App News, Cube Pharmaceuticals (003020.SZ) issued an announcement. Recently, the company received the “Notice of Approval of the Marketing Application for Chemical Ingredient” for dextrophenide hydrochloride issued by the State Drug Administration. Dextrophenidate hydrochloride is a central nervous system stimulant used to treat attention deficit hyperactivity disorder (ADHD).